Hydrocephalus due to Congenital Stenosis of Aqueduct of SylviusSymptoms, Doctors, Treatments, Advances & More
Hydrocephalus due to Congenital Stenosis of Aqueduct of Sylvius Overview
Learn About Hydrocephalus due to Congenital Stenosis of Aqueduct of Sylvius
- Hydrocephalus due to congenital stenosis of aqueduct of sylvius
- Aqueductal stenosis, X-linked
- HSAS
- HSAS1
- HYCX
- Hydrocephalus, X-linked
- XLAS
Advocate Medical Group Neurosurgery
Juan Tejada is a Neurosurgery provider practicing medicine in Libertyville, Illinois. Dr. Tejada is rated as an Experienced provider by MediFind in the treatment of Hydrocephalus due to Congenital Stenosis of Aqueduct of Sylvius. He is also highly rated in 23 other conditions, according to our data. His clinical expertise encompasses Primitive Neuroectodermal Tumor (PNET), Posterior Fossa Tumor, Apoplexy, Awake Craniotomy, and Microdiscectomy. Dr. Tejada is board certified in American Board Of Neurological Surgery.
Ricardo Komotar is an Oncologist and a Neurosurgery provider practicing medicine in Miami, Florida. Dr. Komotar is rated as an Advanced provider by MediFind in the treatment of Hydrocephalus due to Congenital Stenosis of Aqueduct of Sylvius. He is also highly rated in 57 other conditions, according to our data. His clinical expertise encompasses Brain Tumor, Meningioma, Glioblastoma, Awake Craniotomy, and Posterior Fossa Decompression. Dr. Komotar is currently accepting new patients.
Neurosurgical Associates Of New Jersey
Jonathan Lustgarten is a Neurosurgery provider practicing medicine in Eatontown, New Jersey. Dr. Lustgarten is rated as a Distinguished provider by MediFind in the treatment of Hydrocephalus due to Congenital Stenosis of Aqueduct of Sylvius. He is also highly rated in 13 other conditions, according to our data. His clinical expertise encompasses Hydrocephalus due to Congenital Stenosis of Aqueduct of Sylvius, Radiation Induced Meningioma, Meningioma, Microdiscectomy, and Cervical Disc Surgery.
Summary: The Congenital Muscle Disease Patient and Proxy Reported Outcome Study (CMDPROS) is a longitudinal 10 year study to identify and trend care parameters, adverse events in the congenital muscle diseases using the Congenital Muscle Disease International Registry (CMDIR) to acquire necessary data for adverse event calculations (intake survey and medical records curation). To support this study and bec...
Published Date: May 02, 2022
Published By: Genetic and Rare Diseases Informnation Center

